Skip to main content
. 2019 Jun 19;9:529. doi: 10.3389/fonc.2019.00529

Figure 1.

Figure 1

Kaplan-Meier estimates of infield progression-free rate (A) and severe late toxicity-free rate (B) according to groups divided by treatment aim (Group 1, salvage reRT with a surgical component; Group 2, definitive reRT; Group 3, palliative reRT).